ViewPoint Therapeutics competitorsClear all

ViewPoint Therapeutics's top competitors include Abliva, Molecular Partners, Prevail Therapeutics and Y-mAbs Therapeutics.
ViewPoint Therapeutics
ViewPoint Therapeutics
ViewPoint Therapeutics is a biotechnology company which develops treatments for diseases of protein misfolding, including cataracts.
Abliva
Abliva
Abliva (formerly NeuroVive Pharmaceutical) is a company engaged in the research and development of mitochondrial medicine.
Molecular Partners
Molecular Partners
Molecular Partners is a clinical-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of biopharmaceutical products.
Prevail Therapeutics
Prevail Therapeutics
Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease.
Y-mAbs Therapeutics
Y-mAbs Therapeutics
Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.
Founding Date
Founding Date
2014
Founding Date
1998
Founding Date
2004
Founding Date
2017
Founding Date
2014
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
San Francisco, US
Locations
Lund, SE HQ
Locations
Zürich-Schlieren, CH HQ
Cambridge, US
Locations
New York, US HQ
Locations
New York, US HQ
Hørsholm, DK
Nutley, US
Nutley, US
Employees
Employees
730% decrease
Employees
10
Employees
143
Employees
489% increase
Employees
3239% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
29.2 m
Valuation ($)
N/A
Valuation ($)
787.7 m
Valuation ($)
1.8 b
Alexa Website Rank
Alexa Website Rank
307801
Alexa Website Rank
356066
Alexa Website Rank
155980
Alexa Website Rank
333855
Alexa Website Rank
373863

Financial

Net income
Net income
N/A
Net income
N/A
Net income
N/A
Net income
($63.2m) (FY, 2019)
Net income
($81m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 39m
Total funding raised
$ 10.8m
Total funding raised
N/A
Total funding raised
$ 125m
Total funding raised
$ 80m
For sources of this data, please see the company profile

View company profiles

Abliva
HQ
Lund, SE
Employees
10

Abliva (formerly NeuroVive Pharmaceutical) is a company engaged in the research and development of mitochondrial medicine.

View company
Molecular Partners
HQ
Zürich-Schlieren, CH
Employees
143

Molecular Partners is a clinical-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of biopharmaceutical products.

View company
Prevail Therapeutics
HQ
New York, US
Employees
48↑ 9% increase

Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease.

View company
Y-mAbs Therapeutics
HQ
New York, US
Employees
32↑ 39% increase

Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.

View company